Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

0

Number of overlapping holdings

0.0%

% of CANC's 48 holdings also in XDNA

nan%

% of XDNA's 3 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XDNA
Overlap

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
REVOLUTION MEDICINES, INC. 5.7%
ROCHE HOLDINGS LTD-SPONS ADR 4.9%
ELI LILLY & CO 4.9%
BRIDGEBIO PHARMA, INC. 4.4%
ASTRAZENECA PLC 4.1%
NOVARTIS AG 4.1%
SUMMIT THERAPEUTICS INC 4.1%
NUVALENT, INC. CLASS A 3.9%
EXELIXIS INC 3.8%
BRISTOL-MYERS SQUIBB CO 3.7%
CANC Underweight Relative to XDNA
AUTOLUS THERAPEUTICS PLC SPONSORED A 0.2%
CELCUITY INC. 0.3%
ORIC PHARMACEUTICALS INC 0.3%
ILLUMINA INC 0.4%
ARVINAS, INC. 0.4%
RELAY THERAPEUTICS, INC. 0.4%
SYNDAX PHARMACEUTICALS INC 0.4%
GUARDANT HEALTH, INC. 0.5%
ARCUS BIOSCIENCES, INC. 0.5%
CULLINAN ONCOLOGY, INC. 0.5%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY